From there, its about ongoing treatment and periodic biomarker evaluations
FM 2.0 principle : Quantify vitality, not just volume
Diabetes and weight-loss trials have shown that the GLP-1 drugs target hormones in the gut and the brain that control appetite and feelings of fullness, cutting down on what's described as food noise, or intrusive thoughts of food
When given to DIO mice, both peptides led to significant weight reduction, improved glucose tolerance, increased energy expenditure, and reductions in plasma cholesterol and liver steatosis
A final point most people overlook: Semaglutide has demonstrated sustained weight reduction benefits even after treatment ends, provided lifestyle changes are maintained, whereas weight regain tends to be faster after liraglutide discontinuation, says Rasoul Montazeri, MD, a triple board-certified physician based in Irvine, California
Normally, the signal only lasts for only a short interval, but when the amount of GLP-1 is increased by giving yourself an injection, our hunger is decreased throughout the entirety of the day
